# Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

> PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41862113-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-11
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41862113-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41862113-tirzepatide-v1.json
- Content SHA-256: `fdaec88f85438df73bdd43f9f09865a7246a479580c1b359f0f6cbc646702070`

## Claims and source pins

### Headline

Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study. ([`pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea`](#source-pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea))

### Summary

PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea`](#source-pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea))

### Paragraph 1

PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea`](#source-pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea`](#source-pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea))

## Sources

<a id="source-pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea"></a>
- **Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study. · retained source version 1:2026-07-11:current:cb0ea16db9ea9913d75b921176b4278f35948394b5a8e16bbfe383c39dfb36f4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41862113/) (`pubmed-observation-pmid-41862113-2026-07-11-cb0ea16db9ea`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41862113-tirzepatide-v1.json SHA-256: fdaec88f85438df73bdd43f9f09865a7246a479580c1b359f0f6cbc646702070.